7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Differences in genetic and epigenetic alterations between von Hippel–Lindau disease–related and sporadic hemangioblastomas of the central nervous system

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="d6741516e223"> <!-- named anchor --> </a> <h5 class="section-title" id="d6741516e224">Background</h5> <p id="d6741516e226">Although inactivation of the von Hippel–Lindau gene ( <i>VHL</i>), located on chromosome 3p25, is considered to be a major cause of hemangioblastomas (HBs), the incidence of biallelic inactivation of <i>VHL</i> is reportedly low. The aim of this study was to determine the prevalence of <i>VHL</i> alterations in HBs, as well as to identify additional molecular aberrations. </p> </div><div class="section"> <a class="named-anchor" id="d6741516e237"> <!-- named anchor --> </a> <h5 class="section-title" id="d6741516e238">Methods</h5> <p id="d6741516e240">Genetic and epigenetic alterations were comprehensively and comparatively analyzed in 11 VHL-related and 21 sporadic HBs. </p> </div><div class="section"> <a class="named-anchor" id="d6741516e242"> <!-- named anchor --> </a> <h5 class="section-title" id="d6741516e243">Results</h5> <p id="d6741516e245"> <i>VHL</i> alterations detected by sequencing and multiplex ligation-dependent probe amplification (MLPA) analysis were more frequent in VHL-related HBs than in sporadic HBs (100% vs 62%; <i>P</i> = 0.029). <i>VHL</i> alterations were found only in 4 sporadic HBs by direct sequencing; however, targeted deep sequencing detected 9 additional alterations. Loss of heterozygosity (LOH) on chromosome 3 was found in 64% and 57% of VHL-related and sporadic HBs, respectively, by single nucleotide polymorphism (SNP) array analysis. Among 19 tumors with chromosome 3 LOH, 5 were classified as copy-neutral LOH. <i>VHL</i> promoter hypermethylation was detected only in sporadic HBs (33%), indicating that epigenetic suppression of <i>VHL</i> is a common mechanism in sporadic HBs. The rate of biallelic <i>VHL</i> inactivation among VHL-related and sporadic HBs was 64% and 52%, respectively. LOH on either chromosome 6 or 10 was detected only in sporadic HBs (43%). </p> </div><div class="section"> <a class="named-anchor" id="d6741516e266"> <!-- named anchor --> </a> <h5 class="section-title" id="d6741516e267">Conclusion</h5> <p id="d6741516e269">Although biallelic inactivation of <i>VHL</i> is a dominant mechanistic cause of the pathogenesis of HB, other unknown mechanisms may also be involved, and such mechanisms may be different between VHL-related and sporadic HB. </p> </div>

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          BAP1 loss defines a new class of renal cell carcinoma

          The molecular pathogenesis of renal cell carcinoma (RCC) is poorly understood. Whole-genome and exome sequencing followed by innovative tumorgraft analyses (to accurately determine mutant allele ratios) identified several putative two-hit tumor suppressor genes including BAP1. BAP1, a nuclear deubiquitinase, is inactivated in 15% of clear-cell RCCs. BAP1 cofractionates with and binds to HCF-1 in tumorgrafts. Mutations disrupting the HCF-1 binding motif impair BAP1-mediated suppression of cell proliferation, but not H2AK119ub1 deubiquitination. BAP1 loss sensitizes RCC cells in vitro to genotoxic stress. Interestingly, BAP1 and PBRM1 mutations anticorrelate in tumors (P=3×10−5), and combined loss of BAP1 and PBRM1 in a few RCCs was associated with rhabdoid features (q=0.0007). BAP1 and PBRM1 regulate seemingly different gene expression programs, and BAP1 loss was associated with high tumor grade (q=0.0005). Our results establish the foundation for an integrated pathological and molecular genetic classification of RCC, paving the way for subtype-specific treatments exploiting genetic vulnerabilities.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              von Hippel-Lindau disease.

              von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome 3. This disorder is not rare (about one in 36000 livebirths) and is inherited as a highly penetrant autosomal dominant trait (ie, with a high individual risk of disease). Affected individuals are at risk of developing various benign and malignant tumours of the central nervous system, kidneys, adrenal glands, pancreas, and reproductive adnexal organs. Because of the complexities associated with management of the various types of tumours in this disease, treatment is multidisciplinary. We present an overview of the clinical aspects, management, and treatment options for von Hippel-Lindau disease.
                Bookmark

                Author and article information

                Journal
                Neuro-Oncology
                Oxford University Press (OUP)
                1522-8517
                1523-5866
                September 2017
                September 01 2017
                March 30 2017
                September 2017
                September 01 2017
                March 30 2017
                : 19
                : 9
                : 1228-1236
                Article
                10.1093/neuonc/nox034
                5570160
                28379443
                cfe36387-6ef0-4105-b1e3-2bf650250716
                © 2017
                History

                Comments

                Comment on this article